1. Scotti G, Scialfa G, Tampieri D, Landoni L. MR imaging in Fahr disease. J Comput Assist Tomogr. 1985. 9:790–792.
Article
2. Manyam BV, Bhatt MH, Moore WD, Devleschoward AB, Anderson DR, Calne DB. Bilateral striopallidodentate calcinosis: cerebrospinal fluid, imaging, and electrophysiological studies. Ann Neurol. 1992. 31:379–384.
Article
3. Kobari M, Nogawa S, Sugimoto Y, Fukuuchi Y. Familial idiopathic brain calcification with autosomal dominant inheritance. Neurology. 1997. 48:645–649.
Article
4. Geschwind DH, Loginov M, Stern JM. Identification of a locus on chromosome 14q for idiopathic basal ganglia calcification (Fahr disease). Am J Human Genet. 1999. 65:764–772.
Article
5. Kim SH, Yoo BG, Kim KS, Yoo KM, Joh YD. Familial idiopathic striopallidodentate calcifications. J Korean Neurol Assoc. 2003. 21:191–194.
6. Manyam BV, Walters AS, Narla KR. Bilateral striopallidodentate calcinosis: clinical characteristics of patients seen in a registry. Mov Disord. 2001. 16:258–264.
Article
7. Trautner RJ, Cummings JL, Read SL, Benson DF. Idiopathic basal ganglia calcification and organic mood disorder. Am J Psychiatry. 1988. 145:350–353.
Article
8. Lopez-Villegas D, Kulisevsky J, Deus J, Junque C, Pujol J, Guardia E, et al. Neuropsychological alterations in patients with computed tomography-detected basal ganglia calcification. Arch Neurol. 1996. 53:251–256.
Article
9. Benke T, Karner E, Seppi K, Delazer M, Marksteiner J, Donnemiller E. Subacute dementia and imaging correlates in a case of Fahr's disease. J Neurol Neurosurg Psychiatry. 2004. 75:1163–1165.
Article
10. Saver JL, Liu GT, Charness ME. Idiopathic striopallidodentate calcification with prominent supranuclear abnormality of eye movement. J Neuroophthalmol. 1994. 14:29–33.
Article
11. Galvez-Jimenez N, Hanson MR, Cabral J. Dopa-resistant parkinsonism, oculomotor disturbances, chorea, mirror movements, dyspraxia, and dementia: the expanding clinical spectrum of hypoparathyroidism. A case report. Mov Disord. 2000. 15:1273–1276.
Article
12. Calabrese VP, Hadfield MG. Parkinsonism and extraocular motor abnormalities with unusual neuropathological findings. Mov Disord. 1991. 6:257–260.
Article
13. Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology. 1996. 47:1–9.
Article
14. Lowe J, Lennox G, Leigh PN. Graham DI, Lantos PL, editors. Disorders of movement disorders and system degenerations. Green-field's Neuropathology. 1997. Vol II:6th edn. London: Arnold;281–366.
15. Bronsky D, Kushner DS, Dubin A, Snapper I. Idiopathic hypoparathyroidism and pseudohypoparathyroidism: case reports and review of the literature. Medicine. 1958. 37:317–352.
Article
16. Nath U, Ben-Shlomo Y, Thomson RG, Morris HR, Wood NW, Lees AJ, et al. The prevalence of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) in the UK. Brain. 2001. 124:1438–1449.
Article
17. Vaamonde J, Legarda I, Jimenez-Jimenez J, Zubieta JL, Obeso JA. Levodopa-responsive parkinsonism associated with basal ganglia calcification and primary hypoparathyroidism. Mov Disord. 1993. 8:398–400.
Article
18. Hempel A, Henze M, Berghoff C, Garcia N, Ody R, Schroder J. PET findings and neuropsychological deficits in a case of Fahr's disease. Psychiatry Res. 2001. 108:133–140.
Article
19. Hikosaka O, Takikawa Y, Kawagoe R. Role of the basal ganglia in the control of purposive saccadic eye movements. Physiol Rev. 2000. 80:953–978.
Article